physicians, pharmacists, nurses, psychologists as well as other interested healthcare providers, anthropologists, economists, policy makers and industry. Such an interdisciplinary symposium facilitates exchange of ideas across professional and regional boundaries.
A wide range of topics are regularly debated at the annual symposium, with the aim of increasing and disseminating important knowledge and competences within the adherence area. Main topics are described below: Moreover, in order to increase professional education, analytical competencies and effective translation of research into practice, the ESPACOMP organizes every year an educational pre-conference day. The symposium also encourages junior researchers to present and discuss their results during poster sessions and oral communications.
The ESPACOMP aims to strengthen connections to other professional and scientific societies, or scientific projects in order to disseminate knowledge. To note, several founding members of ESPACOMP were involved in the European ABC project (www.abcproject.eu), which revisited the adherence taxonomy and reviewed determinants of medication adherence [1, 2] . It also endorsed a meta-analysis on adherence-enhancing interventions through electronically compiled drug dosing histories, published a review on an educational framework for managing and supporting medication adherence in Europe and developed practical consensus-based policy solutions [3] [4] [5] .
Patient adherence has been a health issue for many chronic patients since long. Due to its multi-factorial and multi-level determinants, patient adherence issues have to be addressed by a wide range of stakeholders from drug development and science areas, to healthcare systems politicians and, professional educators and providers. Alongside with other carers, pharmacists are part of this venture in order to ensure effective, safe and efficient use of medicine in community care. New challenges have arisen with the breakthrough of more targeted but also expensive drugs, within a healthcare environment of cost containment. To improve adherence and persistence, also for newer therapies, high quality research, appropriate education and robust interventions are necessary.
Ten years ago, the World health Organization reported that healthcare systems have to evolve from acute to chronic oriented-care in order to address non adherence and non persistence more efficiently [6] . We are not there yet, but ESPACOMP among other scientific, professional and political initiatives will help disseminate needed knowledge and competencies.
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